Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · IEX Real-Time Price · USD
72.18
-0.34 (-0.47%)
Apr 19, 2024, 3:09 PM EDT - Market open

Ligand Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014 2013 - 1995
Market Capitalization
1,2761,2451,1282,5811,6001,8322,8842,8902,1242,1601,065
Upgrade
Market Cap Growth
-10.35%-56.28%61.30%-12.63%-36.49%-0.20%36.08%-1.70%102.77%-0.76%
Upgrade
Enterprise Value
1,2611,2281,1712,5651,6461,4122,7242,9092,1922,1571,093
Upgrade
PE Ratio
23.75--33.8345.18-536.112.9120.12230.17-1298.099.4088.61
Upgrade
PS Ratio
--5.7510.699.7815.2311.4720.4819.4930.0416.51
Upgrade
PB Ratio
1.821.781.893.142.262.395.147.236.229.1140.48
Upgrade
P/FCF Ratio
-323.11-323.119.4036.6031.08-57.4415.7530.9251.5657.4554.47
Upgrade
P/OCF Ratio
25.7825.128.1932.7629.32-62.4414.8632.6334.9751.7751.81
Upgrade
EV/Sales Ratio
--5.9710.6210.0611.7410.8320.6220.1230.0016.93
Upgrade
EV/EBITDA Ratio
--17.6019.9733.791.6111.5335.3066.7941.3854.77
Upgrade
EV/EBIT Ratio
--121.1535.3286.041.7012.2941.15101.8143.5763.19
Upgrade
EV/FCF Ratio
-318.76-318.769.7636.3631.96-44.2814.8731.1253.2357.3755.87
Upgrade
Debt / Equity Ratio
0.010.010.150.400.640.851.130.560.620.857.44
Upgrade
Debt / EBITDA Ratio
--1.322.539.370.742.692.726.493.879.82
Upgrade
Debt / FCF Ratio
-1.60-1.600.734.608.86-20.393.472.405.175.3710.02
Upgrade
Quick Ratio
3.333.330.7610.244.6864.7110.360.970.700.957.96
Upgrade
Current Ratio
14.1514.152.6711.155.0066.0910.580.990.720.968.13
Upgrade
Asset Turnover
--0.200.190.130.070.170.220.180.180.35
Upgrade
Interest Coverage
--5.373.700.7023.294.595.251.684.203.56
Upgrade
Return on Equity (ROE)
---4.40%7.20%-0.40%67.30%24.30%3.20%-0.50%145.10%24.10%
Upgrade
Return on Assets (ROA)
---3.30%4.50%-0.20%37.20%9.60%1.90%-0.30%57.70%6.50%
Upgrade
Return on Capital (ROIC)
---1.88%9.78%3.22%44.98%11.31%2.39%-1.49%37.92%8.54%
Upgrade
Earnings Yield
--2.96%2.21%-0.19%34.36%4.97%0.43%-0.08%10.64%1.13%
Upgrade
FCF Yield
-0.30%-0.31%10.64%2.73%3.22%-1.74%6.35%3.23%1.94%1.74%1.84%
Upgrade
Buyback Yield / Dilution
-3.37%-3.37%2.19%-2.50%14.84%17.91%-2.50%-12.72%1.87%0.96%-3.32%
Upgrade
Total Shareholder Return
-3.37%-3.37%2.19%-2.50%14.84%17.91%-2.50%-12.72%1.87%0.96%-3.32%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).